PRESS RELEASE published on 05/27/2024 at 07:00, 2 years 2 months ago Communiqué de presse : La FDA accorde un examen prioritaire au Sarclisa pour le traitement des patients atteints d’un myélome multiple nouvellement diagnostiqué non éligibles à une transplantation La FDA accorde l'examen prioritaire au Sarclisa pour le traitement du myélome multiple nouvellement diagnostiqué non éligibles à une transplantation. Sanofi annonce des résultats positifs de l'étude IMROZ FDA Sanofi Myélome Multiple Sarclisa Examen Prioritaire
BRIEF published on 05/21/2024 at 07:35, 2 years 2 months ago Sanofi, Formation Bio, and OpenAI Announce AI Collaboration Collaboration AI Drug Development Sanofi OpenAI Formation Bio
BRIEF published on 05/21/2024 at 07:35, 2 years 2 months ago Sanofi, Formation Bio et OpenAI annoncent une collaboration en matière d'IA Collaboration Développement De Médicaments IA Sanofi OpenAI Biographie De La Formation
PRESS RELEASE published on 05/21/2024 at 07:30, 2 years 2 months ago Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently Collaboration Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE published on 05/21/2024 at 07:30, 2 years 2 months ago Communiqué de presse : Sanofi, Formation Bio et OpenAI annoncent une coopération de première classe autour de l’IA Sanofi, Formation Bio et OpenAI annoncent une coopération pour développer des logiciels alimentés par l'IA afin d'accélérer le développement de médicaments. Première collaboration de ce genre dans les industries pharmaceutiques et des sciences de la vie IA Sanofi Développement De Médicaments OpenAI Formation Bio
BRIEF published on 05/20/2024 at 22:59, 2 years 2 months ago Sanofi: April 2024 Voting Rights and Shares Information Voting Rights Shares Financial Disclosure April 2024 Sanofi
BRIEF published on 05/20/2024 at 22:59, 2 years 2 months ago Sanofi : Informations sur les droits de vote et les actions d'avril 2024 Actions Droit De Vote Divulgation Financière Avril 2024 Sanofi
PRESS RELEASE published on 05/20/2024 at 22:54, 2 years 2 months ago Sanofi: Information concerning the total number of voting rights and shares - April 2024 Sanofi provides total number of issued shares and voting rights as per French Commercial Code and AMF regulations for April 30, 2024 Share Capital Voting Rights French Commercial Code AMF Regulations Sanofi
PRESS RELEASE published on 05/20/2024 at 22:54, 2 years 2 months ago Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2024 Annonce du nombre total de droits de vote et d'actions de Sanofi selon les réglementations en vigueur. Informations disponibles sur le site internet de l'entreprise Autorité Des Marchés Financiers Droits De Vote Actions Relations Investisseurs Sanofi
BRIEF published on 05/20/2024 at 20:20, 2 years 2 months ago Dupixent® réduit les exacerbations de la BPCO selon une étude de phase III FDA Étude Clinique Inflammation BPCO Dupixent
Published on 08/12/2026 at 00:00, 5 hours 9 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 5 hours 29 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 5 hours 54 minutes ago Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 6 hours 9 minutes ago Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 6 hours 14 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 08/12/2026 at 00:18, 4 hours 51 minutes ago EQS-Adhoc: Hawesko Holding SE updates forecast for the 2026 financial year
Published on 08/11/2026 at 22:10, 6 hours 59 minutes ago Quantinuum Reports Second Quarter 2026 Results
Published on 08/11/2026 at 22:05, 7 hours 4 minutes ago Quantinuum and Oracle Partner to Accelerate Hybrid Quantum Compute Adoption on Oracle Cloud Infrastructure
Published on 08/11/2026 at 18:59, 10 hours 10 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC realignment leads to adjustment of FY 2025/26 EBIT guidance; Order intake and sales outlook updated based on current business performance
Published on 08/11/2026 at 18:02, 11 hours 7 minutes ago TerraMaster lance officiellement son programme de mise à niveau du stockage : boostez votre capacité de stockage pour entrer dans l’ère de l’IA
Published on 08/11/2026 at 17:45, 11 hours 24 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 11 hours 29 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 1 day 11 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 day 11 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026